Shi Jiao
Overview
Explore the profile of Shi Jiao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1546
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wen F, Han Y, Zhang H, Zhao Z, Wang W, Chen F, et al.
Nat Commun
. 2024 Dec;
15(1):10543.
PMID: 39627192
Extracellular vesicles (EVs) are known to mediate cell communications and shape tumor microenvironment. Compared to the well-studied small EVs, the function of large microvesicles (MVs) during tumorigenesis is poorly understood....
2.
Tang Y, Chen F, Fang G, Zhang H, Zhang Y, Zhu H, et al.
EMBO J
. 2024 Oct;
43(22):5586-5612.
PMID: 39358623
Transcriptional factors (TFs) act as key determinants of cell death and survival by differentially modulating gene expression. Here, we identified many TFs, including TEAD4, that form condensates in stressed cells....
3.
Nie P, Cao Z, Yu R, Dong C, Zhang W, Meng Y, et al.
Nat Immunol
. 2024 Aug;
25(9):1623-1636.
PMID: 39107403
Targeting tumor-infiltrating regulatory T (TI-T) cells is a potential strategy for cancer therapy. The ATPase p97 in complex with cofactors (such as Npl4) has been investigated as an antitumor drug...
4.
Zhang W, Wang S, Zhang H, Meng Y, Jiao S, An L, et al.
Cancer Biol Med
. 2024 Jun;
21(7).
PMID: 38940675
Gastric cancer (GC) is a major cause of cancer-related mortality worldwide. GC is determined by multiple (epi)genetic and environmental factors; can occur at distinct anatomic positions of the stomach; and...
5.
Reactivating Hippo by drug compounds to suppress gastric cancer and enhance chemotherapy sensitivity
Cao Z, Hou Y, Zhao Z, Zhang H, Tian L, Zhang Y, et al.
J Biol Chem
. 2024 Apr;
300(6):107311.
PMID: 38657866
The Hippo signaling pathway plays an essential role in organ size control and tumorigenesis. Loss of Hippo signal and hyper-activation of the downstream oncogenic YAP signaling are commonly observed in...
6.
Ju J, Zhang H, Lin M, Yan Z, An L, Cao Z, et al.
J Clin Invest
. 2024 Mar;
134(10).
PMID: 38512451
Lactylation has been recently identified as a new type of posttranslational modification occurring widely on lysine residues of both histone and nonhistone proteins. The acetyltransferase p300 is thought to mediate...
7.
An L, Han Y, Jiao S, Zhou Z
Cancer Biol Med
. 2024 Feb;
20(12).
PMID: 38318814
No abstract available.
8.
Meng Y, Zhao Q, Sang Y, Liao J, Ye F, Qu S, et al.
EMBO J
. 2023 Nov;
42(24):e114060.
PMID: 38009297
Hepatocellular carcinoma (HCC) formation is a multi-step pathological process that involves evolution of a heterogeneous immunosuppressive tumor microenvironment. However, the specific cell populations involved and their origins and contribution to...
9.
Jiao S, Li C, Guo F, Zhang J, Zhang H, Cao Z, et al.
Nat Commun
. 2023 Oct;
14(1):6416.
PMID: 37828059
Alteration of the size and stiffness of the nucleus triggered by environmental cues are thought to be important for eukaryotic cell fate and function. However, it remains unclear how context-dependent...
10.
Meng Y, Ye F, Nie P, Zhao Q, An L, Wang W, et al.
J Hepatol
. 2023 Sep;
79(6):1435-1449.
PMID: 37689322
Background & Aims: Remodeling the tumor microenvironment is a critical strategy for treating advanced hepatocellular carcinoma (HCC). Yet, how distinct cell populations in the microenvironment mediate tumor resistance to immunotherapies,...